Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Treasury expected to be harder on China biotech deals in new rules

The pharma industry is bracing for a more stringent assessment of China deals from the Treasury Department, despite months of work to escape a harsh clampdown on buying new assets there. Endpoints News spoke with ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Finance & Markets

More from Wednesday 21 October →